Se espera que el bioprocesamiento de terapia celular alcance los 30.052,61 millones de dólares en 2028 desde los 11.192,50 millones de dólares en 2020. Se estima que el mercado crecerá con una tasa compuesta anual del 13,5 % entre 2021 y 2028.
  ;
El mercado de bioprocesamiento de terapia celular se ha analizado en función de la tecnología, el tipo de célula, el usuario final y la región. El mercado basado en la región está segmentado en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central. El informe hace hincapié en parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de la empresa líder para ofrecer información y un análisis en profundidad del mercado de bioprocesamiento de terapia celular. También incluye el análisis de la pandemia de COVID-19 en todo el mercado en todas las regiones clave.
regiones lucrativas para el mercado de bioprocesamiento de terapia celularPerspectivas del mercado
Crecientes aprobaciones para terapias celulares
Las terapias celulares han mostrado resultados positivos en el tratamiento de diversas enfermedades crónicas, incluidos trastornos genéticos raros, al ofrecer medicinas regenerativas y medicinas personalizadas. La creciente necesidad de tratar enfermedades crónicas ha impulsado las actividades de investigación y desarrollo, lo que ha dado como resultado una creciente producción de terapias celulares y aprobaciones de productos. A continuación se enumeran algunos casos de aprobaciones de terapias celulares que han contribuido al crecimiento del mercado de bioprocesamiento de terapias celulares.
- En mayo de 2019, la Administración de Alimentos y Medicamentos (FDA) aprobó Zolgensma, fabricado por AveXis, Inc. Una subsidiaria de Novartis AG. Zolgensa está diseñado para tratar la atrofia muscular espinal en niños menores de dos años y se administra mediante infusión única en la vena.
- En julio de 2020, Kite Pharma, Inc., una subsidiaria de Gilead Company, recibió la aprobación de la FDA. aprobación para su Tecartus. Tecartus es una terapia de células T (CAR) diseñada para tratar el linfoma de células del manto (MCL) refractario en adultos. Según Toe Gilead Company, Tecartus es la primera terapia con células T (CAR) aprobada para el linfoma de células del manto, que se espera que suponga una nueva frontera en el tratamiento del linfoma de células del manto.
- En febrero de 2021, Juno Therapeutics, Inc., una subsidiaria de Bristol-Myers Squibb Company, recibió la aprobación para su Breyanzi. Breyanzi es una terapia génica basada en células destinada a tratar ciertos tipos de linfoma de células B grandes en adultos. El tratamiento se administra después de que el paciente no haya respondido al menos a otros dos tipos de tratamiento sistémico. Sin embargo, Breyanzi en 2019 enfrentó un revés regulatorio desde su primera presentación; Actualmente se encuentra bajo revisión de la Agencia Europea de Medicamentos y fue validado en julio de 2020.
Por lo tanto, el creciente desarrollo de productos ha dado como resultado varias aprobaciones de productos que reflejan el aumento de las terapias celulares. Por lo tanto, se espera que las crecientes aprobaciones de terapias celulares estén aumentando enormemente el bioprocesamiento de terapias celulares, lo que, a su vez, probablemente impulsará el crecimiento del mercado en los próximos años
Información basada en tecnología
El mercado de bioprocesamiento de terapia celular, por tecnología, se segmenta en biorreactor, liofilización, electrohilado, centrifugación de flujo controlado, lisis ultrasónica, tecnología de edición del genoma, tecnología de inmortalización celular y vector viral. tecnología. El segmento de biorreactor tuvo la mayor participación de mercado en 2020, mientras que se prevé que el segmento de tecnología de edición del genoma registre la CAGR más alta del 14,5 % en el mercado durante el período de pronóstico.
Mercado de bioprocesamiento de terapia celular, por tecnología: 2020 y 2028Información basada en el tipo de célula
El mercado de bioprocesamiento de terapia celular, por tipo de célula, se segmenta en células madre, células inmunitarias y células madre embrionarias humanas. célula, célula madre pluripotente, células madre hematopoyéticas. El segmento de células madre tuvo la mayor participación del mercado en 2020, mientras que se prevé que el mismo segmento registre la CAGR más alta del 14,0% en el mercado durante el período de pronóstico.
< p>Información basada en el usuario finalEl mercado de bioprocesamiento de terapia celular, por indicación, se segmenta en enfermedades cardiovasculares (ECV), oncología, curación de heridas, ortopedia y otras. El segmento de oncología tuvo la mayor participación del mercado en 2020 y se prevé que el segmento ortopédico registre la CAGR más alta del mercado del 14,3 % durante el período de pronóstico.
Perspectivas estratégicas
Las empresas que operan en el mercado de bioprocesamiento de terapia celular están adoptando estrategias orgánicas, como lanzamientos y expansiones de productos, para ampliar su presencia y cartera de productos en todo el mundo, así como para abordar las crecientes demandas.
Por tecnología
- Biorreactor
- Liofilización
- Electrospinning
- Centrifugación de flujo controlado
- Lisis ultrasónica
- Tecnología de edición del genoma
- Tecnología de inmortalización celular
- Tecnología de vectores virales
Por tipo de célula
- Célula madre
- Célula inmunitaria
- Célula madre embrionaria humana
- Célula madre pluripotente
- Célula madre hematopoyética
Por indicación
- Enfermedad cardiovascular (ECV)
- Oncología
- Curación de heridas
- Ortopédico
- Otros
Por usuario final
- Hospitales y clínicas
- Centros de diagnóstico < li>Centros de Medicina Regenerativa
- Instituto Académico y de Investigación
Por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania < li>Italia
- Reino Unido
- España
- Resto de Europa
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- Brasil
- Argentina
- Resto de ESTAFA
Perfiles de la empresa
- Fresenius Kabi AG   ;   ;
- Asahi Kasei Corporation ;
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva ;   ;
- Lonza ;   ;
- Repligen ;   ;
- Catalent Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.
The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.
The List of Companies - Cell Therapy Bioprocessing Market
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)